CAMK2G and breast cancer: Furthermore, we demonstrate herein that CaMKII phosphorylation at T286 is a prognostic factor for breast cancer, and that increased CaMKII expression and T286 phosphorylation indicates poorer overall and distant metastasis free survival in breast cancer patients.